LEO Pharma’s senior area director for South Asia, Ricky Teo, explains the company’s strategy for obtaining growth within such a heterogeneous region and showcases how the organization’s commitment to healthier skin goes beyond commercial prospects and into fundamentally understanding patient mindsets.
How would you describe the essence of LEO Pharma’s business model? And strategically, how has it fared when it comes to markets across South Asia?
Local competency and efficiency is really important to achieve such growth rates—making sure that the organization is able to get more by expending less
